Early use of MR antagonists such as spironolactone, at doses of 2-12.5mg/kg/day, can normalize blood pressure, improve growth, reverse hypertensive retinopathy and left ventricular hypertrophy, and there is literature indicating that it can also reverse bilateral nephrocalcinosis (4, 16). Here, NR3C2 is linked to nephrocalcinosis.